ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Head-To-Head Review: OpGen (OPGN) & Editas Medicine (EDIT) – registrarjournal.com

Head-To-Head Review: OpGen (OPGN) & Editas Medicine (EDIT)registrarjournal.comIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid… Continue reading

2018-03-28 Michael Zand NEWS

Gene therapy may help brain heal from stroke, other injuries – Science Codex

Continue reading

2018-03-28 Michael Zand NEWS

Scientists Who Said CRISPR Is Dangerous Can’t Even Replicate Their Own Results – ScienceAlert

Gene therapy may help brain heal from stroke, other injuries
Science Codex
A new study in mice from UT Southwestern’s O’Donnell Brain Institute shows that turning on a gene inside cells called astrocytes results in a smaller scar and – potentially – a more effective recovery from injury. The research examined spinal injuries …

and more »

Continue reading

2018-03-28 Michael Zand NEWS

Comparing Editas Medicine (EDIT) & NewLink Genetics (NASDAQ:NLNK) – The Lincolnian Online

Comparing Editas Medicine (EDIT) & NewLink Genetics (NASDAQ:NLNK)The Lincolnian OnlineIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucl… Continue reading

2018-03-28 Michael Zand NEWS

EU clears first allogeneic stem cell therapy – PharmaTimes

Scientists Who Said CRISPR Is Dangerous Can’t Even Replicate Their Own Results
ScienceAlert
In their original study, they performed the same analysis – and it was the first time whole-genome sequencing had ever been run on a living organism subjected to CRISPR gene-editing. But unlike the original results, in the new experiments, no …

and more »

Continue reading

2018-03-28 Michael Zand NEWS

Head to Head Analysis: Editas Medicine (EDIT) & NewLink Genetics (NLNK) – The Ledger Gazette

Head to Head Analysis: Editas Medicine (EDIT) & NewLink Genetics (NLNK)The Ledger GazetteIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribon… Continue reading

2018-03-27 Michael Zand NEWS

Preclinical gene therapy biotech Homology Medicines prices upsized IPO at $16 high end – Nasdaq

NasdaqPreclinical gene therapy biotech Homology Medicines prices upsized IPO at $16 high endNasdaqHomology Medicines, a preclinical biotech developing a gene therapy delivery platform for rare diseases, raised $144 million by offering 9 million shares … Continue reading

2018-03-27 Michael Zand NEWS

Researchers engineer yeast to grow on xylose – Ethanol Producer … – Ethanol Producer Magazine

Ethanol Producer MagazineResearchers engineer yeast to grow on xylose – Ethanol Producer …Ethanol Producer MagazineResearchers at Tufts University have created a genetically modified yeast that can more efficiently consume a novel nutrient, xylose, e… Continue reading

2018-03-27 Michael Zand NEWS
  • 1
  • …
  • 336
  • 337
  • 338
  • 339
  • 340
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

PharmaTimes

EU clears first allogeneic stem cell therapy
PharmaTimes
TiGenix and Takeda’s Alofisel has become the first allogeneic stem cell therapy to be approved for use across the European Union. The therapy (previously referred to as Cx601) has been cleared to treat complex perianal fistulas in adult patients with …
Texas Stem Cell Law Opens Door for Controversial Treatments | The …The Scientist
New Jersey is about to legalize marijuana. Our own stem cells should be nextPhillyVoice.com
Alofisel, a Stem Cell Therapy for Crohn’s Disease, Approved in EuropeLabiotech.eu (blog)
Digital Trends –BioPharma-Reporter.com –Zenopa
all 43 news articles »